What the research shows
- Average desire gain 0.5–0.6 vs 0.2 placebo
- Average distress drop 0.7 vs 0.4 placebo
- Desire gains held across 52 weeks
Published study results for the compound, not results from this product. For research use only.
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide studied as an agonist at several melanocortin-receptor subtypes. The Genovare 3mL pen is labelled 50mg, but no sequence, salt or formulation-equivalence evidence is supplied. No batch-specific independent report is linked, so identity, quantity and purity are unverified; this is not presented as an authorised drug product.
- Pack Size
- 3mL
- Product details
- Genovare Catalogue
- Pre-Filled Pen
- Premixed Aqueous
- Storage Guidance
- Follow Package Label
- 1 pre-filled Genovare research pen
- 3 pen needles
- Genovare retail packaging
Genovare Pre-Filled Pen Premixed Aqueous
SpecsPT-141 50mg AQ Pen
Melanocortin agonist tested in phase 3 trials
AED 700 / pen
Choose your bundle
Minimum order is AED 400
25% off orders of AED 700+ with code KV25 at checkout
Order before 4 PM for same-day Dubai delivery.
UAE delivery: AED 50 below AED 1,000; free from AED 1,000
- Sold by
- Remy Research
- Brand
- Genovare
- Manufacturer
- Genovare
- Tested by
- Independent testing not supplied
Ships from Dubai
Technical Specifications
| Manufacturer | Genovare |
|---|---|
| Compound | PT-141 (bremelanotide) |
| Catalogue strength | 50 mg |
| Fill volume | 3mL |
| Format | Aqueous pre-filled pen |
| Pack size | 1 pen with 3 needles |
| Independent testing | Not supplied |